In a video posted to the Giants' social media account, Eli Manning sent a congratulatory video to Dart after the latter met with media. Manning wished Dart well, and said he hopes to root for him ...

Giants icon Eli Manning recorded a message for his fellow Rebel alum, welcoming him into the Big Blue family. Jaxson Dart got a special message from Eli Manning after being drafted by the Giants ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...

The weight loss drug market could grow to $500 billion over the next decade. Eli Lilly's next-generation products look promising, while competitors have stumbled in clinical trials. Investors are ...

Eli Lilly is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare company to do so.Trading at $852 per share, LLY ...

The most recent trading session ended with Eli Lilly (LLY) standing at $827.54, reflecting a +1.16% shift from the previouse trading day's closing. The stock lagged the S&P 500's daily gain of 2.51%.

Given the potential opportunities in the sector, should investors buy Eli Lilly stock? Here's where the company and its stock stand now. The GLP-1 agonist opportunity is gearing up for its next ...

On Friday, former Rebels and Giants QB Eli Manning officially welcomed Dart to the club. One day after hearing his name called in the first round, Dart made the trip up to the Giants facility ...

Pharmaceutical giant Eli Lilly and Co. sued Willow Health Services and three other companies in federal court in New Jersey and California, accusing them of selling unapproved compounded ...

Eli Lilly's Orforglipron shows promising Phase III results, potentially becoming a best-in-class oral GLP-1 receptor agonist for diabetes and obesity by 2026. Despite macroeconomic headwinds ...

Will Jaxson Dart be the Giants’ next Eli Manning, after six mostly brutal seasons of Daniel Jones? Maybe. And if the second time is the charm for the Giants in their post-Manning years ...